MTERFD3 anticorps (N-Term)

N° du produit ABIN6991842

Détail du produit anti-MTERFD3 anticorps

Antigène: MTERFD3 (MTERF Domain Containing 3 (MTERFD3))

Épitope: AA 20-70, N-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MTERFD3 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificité: MTERFD3 antibody is predicted to not cross-react with other MTERFD protein family members.

Purification: MTERFD3 Antibody is affinity chromatography purified via peptide column.

Immunogène: MTERFD3 antibody was raised against an 18 amino acid peptide near the amino terminus of human MTERFD3 . The immunogen is located within amino acids 20 - 70 of MTERFD3.

Isotype: IgG

Information d'application

Indications d'application: MTERFD3 Antibody can be used for detection of MTERFD3 by Western blot at 1 μ,g/mL.

Antibody validated: Western Blot in human samples and Immunohistochemistry in mouse samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: MTERFD3 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: MTERFD3 antibody can be stored at 4°C for three months and -20°C, stable for up to one year.

Détails sur MTERFD3

Antigène: MTERFD3 (MTERF Domain Containing 3 (MTERFD3))

Autre désignation: MTERFD3 (MTERFD3 Produits)

Synonymes: anticorps mTERF2, anticorps mTERFL, anticorps 1700007D05Rik, anticorps Mterf2, anticorps RGD1311836, anticorps mitochondrial transcription termination factor 2, anticorps MTERF2, anticorps Mterf2

Sujet: MTERFD3 Antibody: Members of the mTERF (mitochondrial transcription termination factor) family, are mitochondrial proteins that are believed to be transcription termination factors. MTERFD3 was initially identified through differential display analysis and is expressed primarily in heart, liver, pancreas and skeletal muscle. MTERFD3 is believed to be involved in cell cycle regulation and cell growth by modulating mitochondrial transcription, and may be a serum-inhibitory factor.

Poids moléculaire: Predicted: 42 kDa

Observed: 40 kDa

ID gène: 80298

NCBI Accession: NP_079474

UniProt: Q49AM1